Novita Pharmaceuticals Appoints Alan Wills as Its Chief Executive Officer
February 13, 2023Novita Pharmaceuticals, Inc. (“Novita” or the “Company”), a privately held clinical-stage pharmaceutical company dedicated to developing novel cancer drugs based on its proprietary fascin inhibitor technology, today...